Josephine Keller

Mrs. Josephine Keller

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
CTCinzia Tesauro
Cinzia Tesauro
JKJosephine Keller
Josephine Keller
IGIrina Gromova
Irina Gromova
PGPavel Gromov
Pavel Gromov
RFRikke Frøhlich
Rikke Frøhlich
BKBirgitta Knudsen
Birgitta Knudsen
The heterogeneity of tumor cells and the potential existence of rare cells with reduced chemotherapeutic response is expected to play a pivotal role in the development of drug resistant cancers. Herein, we utilized the colon cancer cell lines, Caco2 and DLD1, to investigate heterogeneity of topoisomerase 1 (TOP1) activity in different cell subpopulations, and the consequences for the chemotherapeutic response towards the TOP1 targeting drug, camptothecin. The cell lines consisted of two subpopulations: one (the stem-cell-like cells) divided asymmetrically, was camptothecin resistant, had a differently phosphorylated TOP1 and a lower Casein Kinase II (CKII) activity than the camptothecin sensitive non-stem-cell-like cells. The tumor suppressor p14ARF had a different effect in the two cell subpopulations. In the stem-cell-like cells, p14ARF suppressed TOP1 activity and downregulation of this factor increased the sensitivity towards camptothecin. It had the opposite effect in non-stem-cell-like cells. Since it is only the stem-cell-like cells that have tumorigenic activity our results point towards new considerations for future cancer therapy. Moreover, the data underscore the importance of considering cell-to-cell variations in the analysis of molecular processes in cell lines.

28 August 2017 in Nanoscale
Verified
Journal Article
Closed access
PDF file
JKJosephine Keller
Josephine Keller
CTCinzia Tesauro
Cinzia Tesauro
ACAndrea Coletta
Andrea Coletta
AGAstrid Damgaard Graversen
Astrid Damgaard Graversen
YHYi-Ping Ho
Yi-Ping Ho
BKBirgitta Knudsen
Birgitta Knudsen
Detection of human topoisomerase I activity in single cells using an on-slide array setup.

1 January 2019
Verified
Book Chapter
Closed access
JKJosephine Keller
Josephine Keller
MSMagnus Stougaard
Magnus Stougaard
BKBirgitta Knudsen
Birgitta Knudsen

24 October 2023 in Biosensors
Verified
Journal Article
Open access
PDF file
JJJuul-Kristensen Juul-Kristensen
Juul-Kristensen Juul-Kristensen
JKJosephine Keller
Josephine Keller
KBKathrine Nygaard Borg
Kathrine Nygaard Borg
NHNoriko Y. Hansen
Noriko Y. Hansen
AFAmalie Foldager
Amalie Foldager
BKBirgitta Knudsen
Birgitta Knudsen
In the modern world with climate changes and increasing pollution, different types of stress are becoming an increasing challenge. Hence, the identification of reliable biomarkers of stress and accessible sensors to measure such biomarkers are attracting increasing attention. In the current study, we demonstrate that the activity, but not the expression, of the ubiquitous enzyme topoisomerase 1 (TOP1), as measured in crude cell extracts by the REEAD sensor system, is markedly reduced in response to thermal stress in both fruit flies (Drosophila melanogaster) and cultivated human cells. This effect was observed in response to both mild-to-moderate long-term heat stress and more severe short-term heat stress in D. melanogaster. In cultivated HeLa cells a reduced TOP1 activity was observed in response to both cold and heat stress. The reduced TOP1 activity appeared dependent on one or more cellular pathways since the activity of purified TOP1 was unaffected by the utilized stress temperatures. We demonstrate successful quantitative measurement of TOP1 activity using an easily accessible chemiluminescence readout for REEAD pointing towards a sensor system suitable for point-of-care assessment of stress responses based on TOP1 as a biomarker.

13 October 2022 in Sensors
Verified
Journal Article
Open access
PDF file
KPKamilla Vandsø Petersen
Kamilla Vandsø Petersen
CTCinzia Tesauro
Cinzia Tesauro
MHMarianne Smedegaard Hede
Marianne Smedegaard Hede
CPCamilla Pages
Camilla Pages
LMLærke Bay Marcussen
Lærke Bay Marcussen
BKBirgitta Knudsen
Birgitta Knudsen
Restriction endonucleases are expressed in all bacteria investigated so far and play an essential role for the bacterial defense against viral infections. Besides their important biological role, restriction endonucleases are of great use for different biotechnological purposes and are indispensable for many cloning and sequencing procedures. Methods for specific detection of restriction endonuclease activities can therefore find broad use for many purposes. In the current study, we demonstrate proof-of-concept for a new principle for the detection of restriction endonuclease activities. The method is based on rolling circle amplification of circular DNA products that can only be formed upon restriction digestion of specially designed DNA substrates. By combining the activity of the target restriction endonuclease with the highly specific Cre recombinase to generate DNA circles, we demonstrate specific detection of selected restriction endonuclease activities even in crude cell extracts. This is, to our knowledge, the first example of a sensor system that allows activity measurements of restriction endonucleases in crude samples. The presented sensor system may prove valuable for future characterization of bacteria species or strains based on their expression of restriction endonucleases as well as for quantification of restriction endonuclease activities directly in extracts from recombinant cells.

27 April 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JKJosephine Keller
Josephine Keller
KPKamilla Vandsø Petersen
Kamilla Vandsø Petersen
KMKarol Mizielinski
Karol Mizielinski
CTCeline Thiesen
Celine Thiesen
LBLotte Bjergbæk
Lotte Bjergbæk
CTCinzia Tesauro
Cinzia Tesauro
With the increasing need for effective compounds against cancer or pathogen-borne diseases, the development of new tools to investigate the enzymatic activity of biomarkers is necessary. Among these biomarkers are DNA topoisomerases, which are key enzymes that modify DNA and regulate DNA topology during cellular processes. Over the years, libraries of natural and synthetic small-molecule compounds have been extensively investigated as potential anti-cancer, anti-bacterial, or anti-parasitic drugs targeting topoisomerases. However, the current tools for measuring the potential inhibition of topoisomerase activity are time consuming and not easily adaptable outside specialized laboratories. Here, we present rolling circle amplification-based methods that provide fast and easy readouts for screening of compounds against type 1 topoisomerases. Specific assays for the investigation of the potential inhibition of eukaryotic, viral, or bacterial type 1 topoisomerase activity were developed, using human topoisomerase 1, Leishmania donovani topoisomerase 1, monkeypox virus topoisomerase 1, and Mycobacterium smegmatis topoisomerase 1 as model enzymes. The presented tools proved to be sensitive and directly quantitative, paving the way for new diagnostic and drug screening protocols in research and clinical settings.